Researchers find that several genetic disorders, including MUC1 kidney disease, may share a novel molecular mechanism—and identify a promising therapeutic lead
The expansion of global biopharmaceutical markets, particularly within nations where electricity and refrigeration are unreliable, drives lyophilization markets